- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Chronic severe disabling pain
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Oxycodone – July 2019
Oxycodone: Tablet containing oxycodone hydrochloride 10 mg (controlled release), Tablet containing oxycodone hydrochloride 15 mg (controlled release), Tablet containing oxycodone hydrochloride 20 mg (controlled release), Tablet containing oxycodone
Last updated
9 July 2025